<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The type and frequency of neurological manifestations of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (BD) vary with ethnicity </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed the neurological manifestations of BD in Japanese patients </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients undergoing treatment at one of the two Yokohama City University hospitals from July 1991 to December 2007 and who fulfilled the Japanese criteria for BD revised in 1987 were studied retrospectively by chart review </plain></SENT>
<SENT sid="3" pm="."><plain>Patients had been neurologically assessed by neurologists </plain></SENT>
<SENT sid="4" pm="."><plain>We recorded neurological signs and symptoms, magnetic resonance imaging or computed tomography findings, and results of cerebrospinal fluid examinations from the records of each patient </plain></SENT>
<SENT sid="5" pm="."><plain>We studied 412 patients with BD, of whom 54 (13%) had neurological involvement (neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease: NB) </plain></SENT>
<SENT sid="6" pm="."><plain>NB patients included a significantly higher proportion of males (61%) than non-NB patients (42%, P = 0.009) </plain></SENT>
<SENT sid="7" pm="."><plain>The majority of patients (n = 38, 70%) had <z:hpo ids='HP_0011009'>acute</z:hpo> parenchymal NB, 15 (28%) had <z:hpo ids='HP_0011010'>chronic</z:hpo> progressive parenchymal NB, and 1 (2%) had the non-parenchymal type </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002315'>Headache</z:hpo> and <z:hpo ids='HP_0001945'>fever</z:hpo> were more frequently reported by patients with <z:hpo ids='HP_0011009'>acute</z:hpo> parenchymal NB </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000751'>Personality changes</z:hpo>, <z:hpo ids='HP_0002839'>sphincter disturbances</z:hpo>, <z:hpo ids='HP_0004305'>involuntary movements</z:hpo>, and <z:hpo ids='HP_0001251'>ataxia</z:hpo> occurred predominantly in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> progressive parenchymal NB </plain></SENT>
<SENT sid="10" pm="."><plain>Lesions were distributed throughout the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>, but mainly in the brainstem, white matter, and basal ganglia </plain></SENT>
<SENT sid="11" pm="."><plain>Analysis of end-point clinical outcomes revealed a poor prognosis for patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> progressive NB </plain></SENT>
<SENT sid="12" pm="."><plain>In Japan, most NB patients have the parenchymal type, and male gender is a predisposing factor </plain></SENT>
<SENT sid="13" pm="."><plain>Because of the unfavorable prognosis associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> progressive NB, development of effective therapies are urgently needed </plain></SENT>
</text></document>